DDX41 and acute myeloid leukemia: This average age at diagnosis falls within the expected age range of MDS/AML in the general population, thus it may be clinically difficult to distinguish patients with de novo MDS/AML from those with a germline predisposition due to a germline mutation in DDX41, and this syndrome may be particularly under-diagnosed.